En esta página
01NUVB precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
NUVB Clase A Nuvation Bio Inc. Class A Common Stock
NYSE · Pharmaceuticals · Ver en SEC EDGAR ↗ 10-K/10-Q Ago 6, 2026
$4,57
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$3,92mínimo 52 semanas
$9,75máximo 52 semanas
Capitalización Bursátil (MRQ)
$1.58B
P/E (TTM)
-10.4
BPA (TTM)
$-0.44
Ingresos (TTM)
$170M
tus insignias
Rango 52S
$4–$10
Calificación del Analista
BUY
Precio Objetivo
$13
P/E
-10.4
ROE
-47.8%
Margen de Beneficio Neto
-88.2%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
NUVB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.57
Capitalización Bursátil (MRQ)
$1.58B
P/E (TTM)
-10.4
BPA (TTM)
$-0.44
Ingresos (TTM)
$170M
ROE (TTM)
-47.8%
Deuda/Capital (MRQ)
0.0
Rango 52S
$4–$10
NUVB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$63M2023-12-31 → 2025-12-31
BPA$-0.602021-12-31 → 2025-12-31
Margen neto-88.2%2024-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | NUVB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -10.4promedio 5A ≈-8.8 | ≈-8.8 | · | · | |
| P/S (TTM) | 9.3 | · | 11.6 | Valor razonable | |
| P/C (MRQ) | 6.2promedio 5A ≈3.7 | ≈3.7 | 4.1 | Sobrevalorado | |
| EV / EBITDA | -5.0 | · | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -9.1promedio 5A ≈-14.0 | ≈-14.0 | · | · | |
| EV / Ingresos (TTM) | 5.5 | · | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 6.5promedio 5A ≈3.2 | ≈3.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | NUVB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -81.0% | · | -62.9% | Débil | |
| EBITDA Margin (Margen EBITDA) | -338.7% | · | -29.4% | Débil | |
| Margen antes de impuestos (TTM) | -88.2% | · | -18.0% | Débil | |
| Margen de Beneficio Neto (TTM) | -88.2% | · | -59.2% | Débil | |
| ROA (TTM) | -21.5%promedio 5A ≈-41.4% | ≈-41.4% | -10.3% | Débil | |
| ROE (TTM) | -47.8%promedio 5A ≈-51.3% | ≈-51.3% | -12.6% | Débil | |
| ROIC | -68.4%promedio 5A ≈-56.3% | ≈-56.3% | -14.8% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | NUVB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.0 | · | 0.4 | Baja deuda | |
| Ratio corriente (MRQ) | 8.4promedio 5A ≈28.1 | ≈28.1 | 10.7 | Por debajo del promedio | |
| Quick Ratio (Ratio Rápido) | 6.4promedio 5A ≈27.6 | ≈27.6 | 9.9 | Por debajo del promedio |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | NUVB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 699.0% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | NUVB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.1 | · | 0.3 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$206.2K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
1.7%
Próximo informe
Nov 11, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 6, 2026 | $-0.15 | $-0.19 | 20.6% |
| 31 de marzo de 2026 | May 19, 2026 | $0.01 | $0.01 | — |
| 31 de diciembre de 2025 | $-0.11 | $-0.09 | -20.7% | |
| 30 de septiembre de 2025 | $-0.16 | $-0.17 | 7.0% | |
| 30 de junio de 2025 | $-0.17 | $-0.17 | 0.87% | |
| 31 de marzo de 2025 | $-0.16 | $-0.16 | 0.93% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $63M | $8M | $0 | |
| Cost of Revenue | · | $7M | $0 | |
| Gross Profit | · | $795.0K | $0 | |
| R&D Expense | $115M | $99M | $71M | |
| SG&A Expense | $152M | $69M | $29M | |
| Operating Expenses | $276M | $600M | $100M | |
| Operating Income | $-213M | $-593M | $-100M | |
| Other Non-op | $2M | $-109.0K | $24M | |
| Pretax Income | $-205M | $-568M | $-76M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-205M | $-568M | $-76M | |
| EPS (Basic) | $-0.60 | $-2.11 | $-0.35 | |
| EPS (Diluted) | $-0.60 | $-2.11 | $-0.35 | |
| Shares (Basic) | 341,541 | 268,772 | 218,880 | |
| Shares (Diluted) | 341,541 | 268,772 | 218,880 | |
| EBITDA | $-213M | $-593M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $164M | $36M | $43M | |
| Short-term Investments | $365M | $467M | $569M | |
| Inventory | $11M | $0 | · | |
| Prepaid Expense | $12M | $7M | $2M | |
| Current Assets | $572M | $526M | $616M | |
| PP&E (Net) | $564.0K | $586.0K | $717.0K | |
| PP&E (Gross) | $2M | $1M | $1M | |
| Accum. Depreciation | $1M | $874.0K | $666.0K | |
| Intangibles | $11M | $5M | $0 | |
| Other Non-current Assets | $8M | $7M | $587.0K | |
| Total Assets | $595M | $541M | $621M | |
| Accounts Payable | $9M | $6M | $2M | |
| Accrued Liabilities | $45M | $33M | $10M | |
| Short-term Debt | $6M | $6M | $0 | |
| Current Liabilities | $82M | $58M | $14M | |
| Capital Leases | $3M | $969.0K | $2M | |
| Total Liabilities | $289M | $77M | $16M | |
| Long-term Debt | $47M | · | · | |
| Total Debt | $6M | $6M | · | |
| Common Stock | $1.42B | $1.37B | $948M | |
| Retained Earnings | $-1.12B | $-911M | $-343M | |
| AOCI | $-187.0K | $573.0K | $181.0K | |
| Stockholders' Equity | $306M | $464M | $605M | |
| Liabilities + Equity | $595M | $541M | $621M | |
| Shares Outstanding | 346,503,675 | 337,837,872 | 219,046,219 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $683.0K | $222.0K | |
| Stock-based Comp | $36M | $32M | $20M | |
| Operating Cash Flow | $-173M | $-130M | $-68M | |
| Investing Cash Flow | $100M | $123M | $9M | |
| Financing Cash Flow | $203M | $331.0K | $628.0K | |
| Net Change in Cash | $128M | $-7M | $-58M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | · | 10.1% | · | |
| Operating Margin | -338.7% | -7527.3% | · | |
| Net Margin | -325.3% | -7213.8% | · | |
| Pretax Margin | -325.3% | -7213.8% | · | |
| EBITDA Margin | -338.7% | -7527.3% | · | |
| ROA | -36.0% | -97.7% | · | |
| ROE | -60.3% | -117.5% | · | |
| ROIC | -68.4% | -126.1% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.0 | 9.0 | · | |
| Quick Ratio | 6.4 | 8.6 | · | |
| Debt / Equity | 0.0 | 0.0 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $0.90 | $1.37 | · | |
| Revenue / Share | $184.17 | $29.29 | · | |
| Cash Flow / Share | $-507.78 | $-485.22 | · | |
| Cash / Share | $0.49 | $0.11 | · | |
| EPS (TTM) | $-0.60 | $-2.11 | $-0.35 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 699.0% | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $63M | $8M | $0 | |
| Net Income TTM | $-205M | $-568M | $-76M | |
| Market Cap | $3.03B | $899M | · | |
| Enterprise Value | $2.50B | $402M | · | |
| P/E | -14.9 | -1.3 | -4.3 | |
| P/S | 48.1 | 114.1 | · | |
| P/B | 9.9 | 1.9 | · | |
| P / Tangible Book | 10.3 | 2.0 | 0.5 | |
| P / Cash Flow | -17.5 | -6.9 | · | |
| EV / EBITDA | -11.8 | -0.7 | · | |
| EV / Revenue | 39.8 | 51.1 | · | |
| Earnings Yield | -6.7% | -79.3% | -23.2% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32M | $83M | $42M | $13M | $5M | $3M | $6M | $727.0K | $1M | $0 | $0 | $0 | $0 | |
| Cost of Revenue | · | · | · | $3M | $3M | $2M | · | $2M | $1M | $0 | · | · | · | |
| Gross Profit | · | · | · | $10M | $2M | $990.0K | · | $-788.0K | $88.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $31M | $35M | $34M | $29M | $27M | $25M | $29M | $28M | $29M | $13M | $15M | $19M | $19M | |
| SG&A Expense | $43M | $38M | $40M | $37M | $38M | $35M | $26M | $20M | $16M | $7M | $5M | $8M | $8M | |
| Operating Expenses | $83M | $79M | $84M | $66M | $68M | $62M | $63M | $47M | $470M | $20M | $21M | $26M | $26M | |
| Operating Income | $-51M | $4M | $-34M | $-56M | $-64M | $-59M | $-54M | $-48M | $-470M | $-20M | $-21M | $-26M | $-26M | |
| Interest Expense | · | · | · | $5M | · | · | · | · | $132.0K | · | · | · | $0 | |
| Other Non-op | $-12M | $2M | $-9M | $642.0K | $5M | $6M | $-20M | $7M | $8M | $5M | $7M | $7M | $5M | |
| Pretax Income | $-63M | $5M | $-37M | $-56M | $-59M | $-53M | $-49M | $-41M | $-462M | $-15M | $-14M | $-20M | $-21M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-63M | $5M | $-37M | $-56M | $-59M | $-53M | $-49M | $-41M | $-462M | $-15M | $-14M | $-20M | $-21M | |
| EPS (Basic) | $-0.18 | $0.02 | $-0.11 | $-0.16 | $-0.17 | $-0.16 | $0.00 | $-0.15 | $-1.89 | $-0.07 | $-0.07 | $-0.09 | $-0.09 | |
| EPS (Diluted) | $-0.18 | $0.01 | $-0.11 | $-0.16 | $-0.17 | $-0.16 | $0.00 | $-0.15 | $-1.89 | $-0.07 | $-0.07 | $-0.09 | $-0.09 | |
| Shares (Basic) | 348,770 | 347,332 | · | 342,393 | 340,746 | 338,612 | · | 273,565 | 244,738 | 219,048 | · | 218,935 | 218,848 | |
| Shares (Diluted) | 348,770 | 377,521 | · | 342,393 | 340,746 | 338,612 | · | 273,565 | 244,738 | 219,048 | · | 218,935 | 218,848 | |
| EBITDA | $-51M | $4M | · | $-56M | $-64M | $-59M | · | $-48M | $-470M | $-20M | · | $-26M | $-26M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $259M | $125M | $164M | $99M | $248M | $48M | $36M | $30M | $34M | $35M | $43M | $24M | $50M | |
| Short-term Investments | $402M | $408M | $365M | $450M | $360M | $414M | $467M | $519M | $543M | $562M | $569M | $595M | $581M | |
| Inventory | $20M | $16M | $11M | $6M | $552.0K | $14.0K | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $14M | $16M | $12M | $9M | $8M | $8M | $7M | $12M | $6M | $7M | $2M | $3M | $4M | |
| Current Assets | $726M | $592M | $572M | $578M | $623M | $476M | $526M | $565M | $587M | $608M | $616M | $625M | $637M | |
| PP&E (Net) | $715.0K | $535.0K | $564.0K | $560.0K | $615.0K | $562.0K | $586.0K | $719.0K | $751.0K | $686.0K | $717.0K | $764.0K | $804.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $971.0K | $874.0K | $839.0K | $782.0K | · | $666.0K | · | · | |
| Intangibles | $10M | $11M | $11M | $12M | $12M | $4M | $5M | $3M | $3M | · | $0 | · | · | |
| Other Non-current Assets | $4M | $4M | $8M | $7M | $7M | $7M | $7M | $480.0K | $1M | $1M | $587.0K | $587.0K | · | |
| Total Assets | $745M | $610M | $595M | $602M | $647M | $492M | $541M | $572M | $595M | $613M | $621M | $631M | $641M | |
| Accounts Payable | $12M | $22M | $9M | $15M | $22M | $11M | $6M | $12M | $5M | $2M | $2M | $2M | $3M | |
| Accrued Liabilities | $45M | $33M | $45M | $33M | $24M | $24M | $33M | $24M | $20M | $11M | $10M | $12M | $10M | |
| Short-term Debt | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $8M | $12M | · | $0 | · | · | |
| Current Liabilities | $87M | $80M | $82M | $68M | $66M | $53M | $58M | $59M | $51M | $16M | $14M | $16M | $13M | |
| Capital Leases | $2M | $2M | $3M | $3M | $3M | $4M | $969.0K | $985.0K | $972.0K | $2M | $2M | $3M | $2M | |
| Total Liabilities | $491M | $291M | $289M | $276M | $274M | $73M | $77M | $69M | $63M | $19M | $16M | $19M | $17M | |
| Long-term Debt | $243M | $47M | $47M | $47M | $47M | · | · | · | · | · | · | · | · | |
| Total Debt | $6M | $6M | · | $6M | $6M | $6M | · | $8M | $12M | · | · | · | · | |
| Common Stock | $1.43B | $1.43B | $1.42B | $1.40B | $1.40B | $1.38B | $1.37B | $1.36B | $1.08B | $953M | $948M | $944M | $938M | |
| Retained Earnings | $-1.17B | $-1.11B | $-1.12B | $-1.08B | $-1.02B | $-964M | $-911M | $-861M | $-820M | $-358M | $-343M | $-329M | $-309M | |
| AOCI | $-3M | $-2M | $-187.0K | $-139.0K | $-327.0K | $545.0K | $573.0K | $1M | $-1M | $-1M | $181.0K | $-3M | $-4M | |
| Stockholders' Equity | $254M | $320M | $306M | $326M | $373M | $419M | $464M | $503M | $257M | $594M | $605M | $612M | $625M | |
| Liabilities + Equity | $745M | $610M | $595M | $602M | $647M | $492M | $541M | $572M | $595M | $613M | $621M | $631M | $641M | |
| Shares Outstanding | 346,503,675 | 346,503,675 | 337,837,872 | 337,837,872 | 337,837,872 | 337,837,872 | 337,837,872 | 336,248,642 | 248,624,729 | 219,083,219 | 219,046,219 | 218,944,053 | 218,899,462 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $536.0K | $536.0K | $539.0K | $534.0K | $356.0K | $310.0K | $219.0K | $162.0K | $244.0K | $58.0K | $55.0K | $55.0K | $56.0K | |
| Stock-based Comp | $10M | $9M | $8M | $8M | $12M | $8M | $10M | $7M | $10M | $5M | $4M | $5M | $6M | |
| Operating Cash Flow | $-43M | $5M | $-30M | $-53M | $-48M | $-43M | $-46M | $-31M | $-37M | $-16M | $-15M | $-16M | $-17M | |
| Investing Cash Flow | $6M | $-44M | $87M | $-97M | $55M | $54M | $52M | $29M | $34M | $8M | $33M | $-10M | $37M | |
| Financing Cash Flow | $171M | $44.0K | $8M | $501.0K | $193M | $548.0K | $-900.0K | $-2M | $3M | $21.0K | $120.0K | $77.0K | $133.0K | |
| Net Change in Cash | $133M | $-39M | $65M | $-149M | $200M | $12M | $6M | $-4M | $-225.0K | $-8M | $18M | $-26M | $20M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 74.5% | 46.7% | 32.1% | · | -108.4% | 6.1% | · | · | · | · | |
| Operating Margin | -161.1% | 4.7% | · | -430.1% | -1315.7% | -1913.2% | · | -6616.4% | -32779.4% | · | · | · | · | |
| Net Margin | -198.3% | 6.5% | · | -425.2% | -1220.9% | -1726.2% | · | -5668.5% | -32229.4% | · | · | · | · | |
| Pretax Margin | -198.3% | 6.5% | · | -425.2% | -1220.9% | -1726.2% | · | -5668.5% | -32229.4% | · | · | · | · | |
| EBITDA Margin | -161.1% | 4.7% | · | -430.1% | -1315.7% | -1913.2% | · | -6616.4% | -32779.4% | · | · | · | · | |
| ROA | -9.0% | 0.98% | · | -9.5% | -9.5% | -9.6% | · | -6.9% | -74.8% | -2.3% | · | -3.0% | -3.0% | |
| ROE | -20.1% | 1.5% | · | -13.5% | -18.7% | -10.5% | · | -7.4% | -104.9% | -2.4% | · | -3.1% | -3.1% | |
| ROIC | -19.7% | 1.2% | · | -17.0% | -16.8% | -13.9% | · | -9.4% | -175.0% | -3.4% | · | -4.3% | -4.2% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 7.4 | · | 8.5 | 9.4 | 9.0 | · | 9.6 | 11.5 | 38.6 | · | 38.7 | 47.5 | |
| Quick Ratio | 7.6 | 6.7 | · | 8.1 | 9.2 | 8.7 | · | 9.3 | 11.3 | 37.9 | · | 38.4 | 47.0 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | -11.0 | · | · | · | · | -3563.5 | · | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | · | · | · | 1.2 | 9.3 | 299.1 | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.73 | $0.92 | · | $0.96 | $1.10 | $1.24 | · | $1.50 | $1.03 | $2.71 | · | $2.79 | $2.85 | |
| Revenue / Share | $90.85 | $220.46 | · | $38.32 | $14.18 | $9.11 | · | $2.66 | $5.86 | · | · | · | · | |
| Cash Flow / Share | · | $13.43 | · | · | · | $-125.89 | · | · | · | $-71.68 | · | · | · | |
| Cash / Share | $0.75 | $0.36 | · | $0.29 | $0.73 | $0.14 | · | $0.09 | $0.14 | $0.16 | · | $0.11 | $0.23 | |
| EPS (TTM) | $-0.44 | $-0.43 | · | $-0.49 | $-0.48 | $-2.20 | · | $-2.18 | $-2.12 | $-0.32 | · | $-0.38 | $-0.41 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $143M | · | $27M | $14M | $11M | · | $2M | $1M | $0 | · | · | · | |
| Net Income TTM | $-150M | $-146M | · | $-217M | $-203M | $-606M | · | $-532M | $-511M | $-69M | · | $-83M | $-90M | |
| Market Cap | $1.97B | $1.49B | · | $1.25B | $659M | $595M | · | $770M | $726M | $797M | · | $293M | $394M | |
| Enterprise Value | $1.31B | $959M | · | $707M | $57M | $139M | · | $229M | $160M | · | · | · | · | |
| P/E | -12.9 | -10.0 | · | -7.6 | -4.1 | -0.8 | · | -1.1 | -1.4 | -11.4 | · | -3.5 | -4.4 | |
| P/S | 11.6 | 10.4 | · | 46.7 | 45.9 | 54.3 | · | 356.2 | 505.9 | · | · | · | · | |
| P/B | 7.8 | 4.7 | · | 3.8 | 1.8 | 1.4 | · | 1.5 | 2.8 | 1.3 | · | 0.5 | 0.6 | |
| P / Tangible Book | 8.1 | 4.8 | · | 4.0 | 1.8 | 1.4 | · | 1.5 | 2.9 | 1.3 | · | 0.5 | 0.6 | |
| P / Cash Flow | · | 293.3 | · | · | · | -13.9 | · | · | · | -50.8 | · | · | · | |
| EV / Revenue | 7.7 | 6.7 | · | 26.4 | 3.9 | 12.6 | · | 106.1 | 111.8 | · | · | · | · | |
| Earnings Yield | -7.8% | -10.0% | · | -13.2% | -24.6% | -125.0% | · | -95.2% | -72.6% | -8.8% | · | -28.4% | -22.8% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $63M | $8M | $0 | · | · |
| Margen Bruto % | · | 10.1% | · | · | · |
| Margen Operativo % | -338.7% | -7527.3% | · | · | · |
| Beneficio neto | $-205M | $-568M | $-76M | $-104M | $-87M |
| EPS Diluido | $-0.60 | $-2.11 | $-0.35 | $-0.48 | $-0.44 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.0 | 0.0 | · | · | · |
| Ratio corriente | 7.0 | 9.0 | · | 50.7 | 45.6 |
| Ratio Rápido | 6.4 | 8.6 | · | 50.2 | 45.2 |
No hay datos para este estado
Aún no hay suficientes datos fundamentales para generar este estado.
Propietarios institucionales (13F) 257 declarantes · $1.5B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
257
Valor en tenencia
$1.5B
Nuevas posiciones
39
Posiciones cerradas
25
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 39 (-9 vs trimestre anterior) | 25 (-8 vs trimestre anterior) | 108 (+20 vs trimestre anterior) | 55 (-6 vs trimestre anterior) | +17.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $296 668 075 | 52 230 295 | 20,30% | Acciones |
| BlackRock, Inc. | $156 943 154 | 27 630 837 | 10,74% | Acciones |
| Decheng Capital LLC | $147 421 214 | 25 954 439 | 10,09% | Acciones |
| VANGUARD GROUP INC | $139 378 229 | 15 555 606 | 9,54% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $67 702 840 | 11 919 514 | 4,63% | Acciones |
| Omega Fund Management, LLC | $45 900 586 | 8 081 089 | 3,14% | Acciones |
| Laurion Capital Management LP | $44 417 674 | 7 820 013 | 3,04% | Acciones |
| STATE STREET CORP | $41 866 110 | 7 370 794 | 2,86% | Acciones |
| UBS Group AG | $36 208 324 | 6 374 705 | 2,48% | Opción de compra |
| GEODE CAPITAL MANAGEMENT, LLC | $35 477 953 | 6 244 805 | 2,43% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $25 557 979 | 4 499 643 | 1,75% | Acciones |
| BANK OF AMERICA CORP /DE/ | $20 048 969 | 3 529 748 | 1,37% | Acciones |
| TANG CAPITAL MANAGEMENT LLC | $18 741 484 | 3 299 557 | 1,28% | Acciones |
| Redmile Group, LLC | $17 216 131 | 3 031 009 | 1,18% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $15 271 623 | 2 688 666 | 1,05% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $13 384 517 | 2 356 429 | 0,92% | Acciones |
| NORTHERN TRUST CORP | $13 188 238 | 2 321 873 | 0,90% | Acciones |
| ALGERT GLOBAL LLC | $12 935 393 | 2 277 358 | 0,89% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11 694 382 | 2 058 870 | 0,80% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $11 631 936 | 2 047 876 | 0,80% | Acciones |
| ARMISTICE CAPITAL, LLC | $11 360 000 | 2 000 000 | 0,78% | Acciones |
| CITADEL ADVISORS LLC | $11 293 715 | 1 988 330 | 0,77% | Acciones |
| GOLDMAN SACHS GROUP INC | $10 818 616 | 1 904 686 | 0,74% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $10 090 827 | 1 776 554 | 0,69% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $9 978 738 | 1 756 820 | 0,68% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $9 211 176 | 1 621 686 | 0,63% | Acciones |
| Knoll Capital Management, LLC | $9 079 996 | 1 598 591 | 0,62% | Acciones |
| MORGAN STANLEY | $8 277 652 | 1 457 333 | 0,57% | Acciones |
| Jump Financial, LLC | $7 715 774 | 1 358 411 | 0,53% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $7 645 252 | 1 345 995 | 0,52% | Acciones |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $7 531 278 | 1 344 871 | 0,52% | Acciones |
| FIRST TRUST ADVISORS LP | $7 397 274 | 1 302 337 | 0,51% | Acciones |
| ABRAMS CAPITAL MANAGEMENT, L.P. | $7 216 463 | 1 270 504 | 0,49% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $7 090 963 | 1 248 409 | 0,49% | Acciones |
| NewEdge Advisors, LLC | $6 996 243 | 1 231 733 | 0,48% | Acciones |
| D. E. Shaw & Co., Inc. | $6 475 200 | 1 140 000 | 0,44% | Acciones |
| UBS Group AG | $6 343 884 | 1 116 881 | 0,43% | Acciones |
| Nuveen, LLC | $6 155 007 | 1 083 628 | 0,42% | Acciones |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5 802 268 | 1 021 526 | 0,40% | Acciones |
| Woodline Partners LP | $5 541 022 | 975 532 | 0,38% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 195 945 | 914 779 | 0,36% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $4 065 637 | 715 781 | 0,28% | Acciones |
| Bank of New York Mellon Corp | $3 803 823 | 669 687 | 0,26% | Acciones |
| Beacon Pointe Advisors, LLC | $3 591 186 | 632 251 | 0,25% | Acciones |
| TWO SIGMA ADVISERS, LP | $3 522 176 | 393 100 | 0,24% | Acciones |
| Invesco Ltd. | $3 336 387 | 587 392 | 0,23% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3 037 431 | 534 759 | 0,21% | Acciones |
| ACT CAPITAL MANAGEMENT, LLC | $2 953 600 | 520 000 | 0,20% | Acciones |
| JPMORGAN CHASE & CO | $2 893 055 | 515 696 | 0,20% | Acciones |
| Swiss National Bank | $2 765 024 | 486 800 | 0,19% | Acciones |
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Claudio Nessi, Otello Stampacchia ×3 presentaciones | 18 de octubre de 2024 | · | Presentación inicial | · | SEC |
| Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Decheng Anbio Limited, Xiangmin Cui | 10 de septiembre de 2024 | · | Presentación inicial | Campaña de la junta directiva | SEC |
| David Hung, M.D. ×2 presentaciones | 26 de marzo de 2024 | · | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 25 insiders · 12 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Junyuan Jerry Wang | CEO, ANHEART THERAPEUTICS LTD. | 11 de noviembre de 2024 S | 3 866 228 | 0 | 0 | $0 |
| Philippe Sauvage | Chief Financial Officer | 15 de julio de 2026 M | 54 131 | 0 | 1 | $-286 485 |
| Jennifer A. Fox | Chief Financial Officer | 28 de febrero de 2023 A | · | 0 | 0 | $0 |
| Gary Hattersley | CHIEF SCIENTIFIC OFFICER | 19 de agosto de 2026 M | 0 | 0 | 4 | $-3 879 239 |
| Stacy Markel | CHIEF PEOPLE OFFICER | 23 de junio de 2026 M | 32 591 | 0 | 1 | $-753 750 |
| Kerry Wentworth | CHIEF REGULATORY OFFICER | 23 de junio de 2026 M | 53 000 | 0 | 3 | $-1 467 378 |
| Dongfang Liu | CHIEF MEDICAL OFFICER | 17 de abril de 2026 M | 18 000 | 0 | 7 | $-1 866 900 |
| Colleen Sjogren | Chief Commercial Officer | 27 de febrero de 2026 A | 81 000 | 0 | 0 | $0 |
| Moses Makunje | Title: VP, Finance and principal financial and accounting officer. | 27 de febrero de 2026 A | 68 137 | 0 | 0 | $0 |
| David C. Hanley | CHIEF TECHNICAL OPERATIONS | 27 de febrero de 2026 A | 24 000 | 0 | 1 | $-1 428 000 |
| Sergey Yurasov | Chief Medical Officer | 10 de febrero de 2021 A | · | 0 | 0 | $0 |
| Thomas Templeman | SVP, Pharmaceutical Ops | 10 de febrero de 2021 A | · | 0 | 0 | $0 |
| Robert Mashal | Consejero | 9 de junio de 2026 P | 225 000 | 1 | 0 | $118 250 |
| Robert B Bazemore | Consejero | 21 de mayo de 2026 A | 5 000 | 0 | 0 | $0 |
| Xiangmin Cui | Consejero | 21 de mayo de 2026 A | 17 062 202 | 0 | 0 | $0 |
| Kathryn E Falberg | Consejero | 21 de mayo de 2026 A | 250 000 | 0 | 0 | $0 |
| Daniel G Welch | Consejero | 24 de mayo de 2024 M | 659 947 | 0 | 0 | $0 |
| Oleg Nodelman | Consejero | 29 de octubre de 2021 A | · | 0 | 0 | $0 |
| Graham K Cooper | Consejero | 10 de febrero de 2021 M | 25 000 | 0 | 0 | $0 |
| Shalini Sharp | Consejero | 10 de febrero de 2021 M | 35 000 | 0 | 0 | $0 |
| Faheem Hasnain | Consejero | 10 de febrero de 2021 M | 55 000 | 0 | 0 | $0 |
| Daniel Bradbury | Consejero | 10 de febrero de 2021 M | 25 000 | 0 | 0 | $0 |
| Anthony W Vernon | · | 21 de mayo de 2026 A | 304 100 | 0 | 0 | $0 |
| Kim D Blickenstaff | · | 21 de mayo de 2026 A | 172 189 | 0 | 0 | $0 |
| David Hung | · | 27 de febrero de 2026 A | 59 281 054 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 38 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,77% | 275 843 NS | 31 de julio de 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,57% | 51 286 NS | 31 de julio de 2026 | N-PORT |
| IDNA · iShares Trust | 1,51% | 613 529 SH | 11 de septiembre de 2026 | Diario |
| PTH · Invesco Exchange-Traded Fund Trust | 1,20% | 732 575 SH | 23 de octubre de 2026 | Diario |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,44% | 909 498 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,37% | 855 978 SH | 11 de septiembre de 2026 | Diario |
| IHE · iShares Trust | 0,35% | 902 180 SH | 11 de septiembre de 2026 | Diario |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,32% | 265 449 SH | 23 de octubre de 2026 | Diario |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,21% | 460 740 NS | 31 de julio de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,18% | 10 233 NS | 31 de julio de 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,12% | 237 789 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,12% | 1 891 272 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,10% | 2 370 008 SH | 11 de septiembre de 2026 | Diario |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,09% | 82 391 NS | 31 de julio de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 270 228 SH | 19 de agosto de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 218 055 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,05% | 6 449 970 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,05% | 120 391 NS | 31 de julio de 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 201 792 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1 450 662 SH | 19 de agosto de 2026 | Diario |
| TECB · iShares Trust | 0,03% | 24 294 SH | 11 de septiembre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 163 106 SH | 23 de octubre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 115 286 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2 787 165 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,02% | 730 126 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,02% | 430 890 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 13 480 SH | 11 de septiembre de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,01% | 405 885 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2 055 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 70 393 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 310 102 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,00% | 5 348 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 37 633 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 8 849 329 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 19 595 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 10 466 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 51 844 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 88 212 SH | 11 de septiembre de 2026 | Diario |
NUVB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 19 analistas
COMPRA
Objetivo mediano
$12.00
+162,6%
5 26,3%
Compra fuerte
12 63,2%
Compra
2 10,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
11 analistas · 2026-10-23Objetivo medio $13.00 +184,5%
← Por Debajo de Todos los Objetivos
Precio Actual $4.57
Mín$7.00
Media$13.00
Máx$21.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| MAZE | $2.04B | -13.6 | · | · | -598.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| PAHC | · | 12.9 | 17.1% | 6.6% | 29.7% | 33.8% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| INVA | · | 6.1 | 14.7% | · | · | · |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026